Meeting ReportAnnual Meeting of the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA), Stockholm, Sweden, June 26–27, 2012
Outcome Measures for Psoriasis Severity: A Report from the GRAPPA 2012 Annual Meeting
Kristina Callis Duffin and Alice B. Gottlieb
The Journal of Rheumatology August 2013, 40 (8) 1423-1424; DOI: https://doi.org/10.3899/jrheum.130454
Kristina Callis Duffin
From the Department of Dermatology, University of Utah, Salt Lake City, Utah; and Tufts Medical Center, Boston, Massachusetts,
USA.

REFERENCES
- 1.↵
- Gladman DD,
- Helliwell PS,
- Khraishi M,
- Callis Duffin K,
- Mease PJ
- 2.↵
- Gottlieb AB,
- Armstrong AW
- 3.↵
- 4.↵
- 5.↵
- 6.↵
- 7.↵Dermatologic and Ophthalmic Drugs Advisory Committee 49th Meeting 1998: Food and Drug Administration, Department of Health and Human Services, Public Health Service, March 20, 1998. Washington, DC: Miller Reporting Company, Inc; 1998.
- 8.↵
- 9.↵
- 10.↵OMERACT — International Consensus Conference on Outcome Measures in Rheumatology Clinical Trials. [updated 2013; cited 18 March 2013]; Available from: www.omeract.org
In this issue
The Journal of Rheumatology
Vol. 40, Issue 8
1 Aug 2013
Outcome Measures for Psoriasis Severity: A Report from the GRAPPA 2012 Annual Meeting
Kristina Callis Duffin, Alice B. Gottlieb
The Journal of Rheumatology Aug 2013, 40 (8) 1423-1424; DOI: 10.3899/jrheum.130454